Stay updated on Neoadjuvant Atezolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Atezolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Neoadjuvant Atezolizumab in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added to the history and Revision v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a government funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe study status was updated to Completed on 2026-01-22 and the prior Active, not recruiting status was removed. UI updates include the glossary display and color-coded highlights for additions and deletions, with a Revision: v3.4.0.SummaryDifference0.7%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with the previous Revision: v3.3.2 have been removed.SummaryDifference0.1%

Stay in the know with updates to Neoadjuvant Atezolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Atezolizumab in Lung Cancer Clinical Trial page.